E2	Drug:T7 Name:T8
E4	Study:T9 Study-Of:E2
E1	Procedure:T1 Temporality:E3
E3	Eq-Comparison:T2 Temporal-Period:T3
E5	Drug:T4
E6	Study:T5 Study-Of:E5
E7	Assertion:T6 Asserted:E5
E8	Observation:T10 Name:T11 Polarity:T12
E9	Procedure:T13 Temporality:E10
E10	Eq-Comparison:T14 Temporal-Period:T15
E11	Procedure:T16 Temporality:E12
E12	Eq-Comparison:T17 Temporal-Period:T18
E13	Drug:T19 Minimum-Count:E14
E14	Eq-Comparison:T20 Value:T21 Operator:T22
E15	Drug:T23 Name:T24
E16	Negation:T25 Negates:E15
E17	Eq-Comparison:T26 Temporal-Period:T27
E18	Drug:T28 Temporality:E17
E19	And:T29 Arg:E18 Arg2:E16
E20	Study:T30 Study-Of:E22
E21	Other:T31 Is-Other:E20
E22	Drug:T32
E23	Assertion:T33 Asserted:E22
E24	And:T34 Arg:E18 Arg2:E23
T7	Drug 102 98	anetumab ravtansine
T8	Drug-Name 102 98	anetumab ravtansine
T9	Study 115 111	study
T1	Procedure 183 175	treatment
T2	Eq-Comparison 171 165	on
T3	Eq-Temporal-Period 171 165	on
T4	Drug 269 260	intervention
T5	Study 256 247	study
T6	Assertion 222 213	eligible
T10	Observation 395 379	serum pregnancy test
T11	Observation-Name 395 379	serum pregnancy test
T12	Polarity 374 358	positive
T13	Procedure 348 333	treatment
T14	Eq-Comparison 336 323	on
T15	Eq-Temporal-Period 336 323	on
T16	Procedure 422 402	treatment
T17	Eq-Comparison 410 392	on
T18	Eq-Temporal-Period 410 392	on
T19	Drug 486 465	medications
T20	Eq-Comparison 456 435	one or more
T21	Eq-Value 448 427	one
T22	Eq-Operator 456 435	or more
T23	Drug 633 603	anetumab ravtansine
T24	Drug-Name 633 603	anetumab ravtansine
T25	Negation 613 583	not
T26	Eq-Comparison 572 549	receiving
T27	Eq-Temporal-Period 572 549	receiving
T28	Drug 605 575	agent(s)
T29	And 609 579	but
T30	Study 736 701	study
T31	Other 714 679	outside
T32	Drug 706 671	agent
T33	Assertion 671 640	able to
T34	And 659 628	and
A1	Eq-Temporal-Period-Value T3 present
A2	Assertion-Type-Value E7 hypothetical
A3	Observation-Type-Value T11 lab
A4	Polarity-Value T12 positive
A5	Eq-Temporal-Period-Value T15 present
A6	Eq-Temporal-Period-Value T18 present
A7	Eq-Operator-Value T22 GTEQ
A8	Eq-Temporal-Period-Value T27 present
A9	Assertion-Type-Value E23 hypothetical
R1	If-Then Arg1:E1 Arg2:E5
R2	If-Then Arg1:E9 Arg2:E8
R3	If-Then Arg1:E11 Arg2:E13